Page last updated: 2024-09-05

sb 203580 and gilteritinib

sb 203580 has been researched along with gilteritinib in 2 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(gilteritinib)
Trials
(gilteritinib)
Recent Studies (post-2010) (gilteritinib)
3,48941,13713512132

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)gilteritinib (IC50)
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 26.76
Cannabinoid receptor 1Rattus norvegicus (Norway rat)0.0007
Leukocyte tyrosine kinase receptorHomo sapiens (human)0.0003
Tyrosine-protein kinase receptor UFOHomo sapiens (human)0.0035
Receptor-type tyrosine-protein kinase FLT3Homo sapiens (human)0.0003
Transcription factor ETV6Homo sapiens (human)0.0085
Echinoderm microtubule-associated protein-like 4Homo sapiens (human)0.0036
ALK tyrosine kinase receptorHomo sapiens (human)0.0024

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Bharate, SB; Raghuvanshi, R1
Laufer, S; Pillaiyar, T1

Reviews

1 review(s) available for sb 203580 and gilteritinib

ArticleYear
Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy.
    Journal of medicinal chemistry, 2022, 01-27, Volume: 65, Issue:2

    Topics: Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Protein Kinase Inhibitors; SARS-CoV-2; Signal Transduction; Virus Replication

2022

Other Studies

1 other study(ies) available for sb 203580 and gilteritinib

ArticleYear
Recent Developments in the Use of Kinase Inhibitors for Management of Viral Infections.
    Journal of medicinal chemistry, 2022, 01-27, Volume: 65, Issue:2

    Topics: Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Approval; Drug Repositioning; High-Throughput Screening Assays; Humans; Protein Kinase Inhibitors; SARS-CoV-2; United States; United States Food and Drug Administration; Virus Diseases

2022